Urinary Biomarker-Based Diagnostic and Monitoring System for Chronic Kidney Disease and Real-World Effectiveness of SGLT2 Inhibitors

NCT07348484 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: Empagliflozin

Sponsor

Instituto de Investigación Biomédica de Salamanca